Guinea-Bissau vs Kyrgyzstan: Total official development assistance to medical research and basic
Guinea-Bissau
15.3
in 2024
Kyrgyzstan
18.4
in 2024
Guinea-Bissau rank
76th
Kyrgyzstan rank
74th
Total official development assistance to medical research and basic over time
- Guinea-Bissau
- Kyrgyzstan
How they compare
Kyrgyzstan currently reports 18.4 against 15.3 in Guinea-Bissau, a difference of 3.1.
That makes Kyrgyzstan's figure about 1.2 times Guinea-Bissau's.
The two have swapped places 9 times across 15 shared years of data; in 2010 it was Guinea-Bissau ahead.
Guinea-Bissau ranks 76th and Kyrgyzstan ranks 74th of 157 countries.
Kyrgyzstan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 22.77 | 22.91 | 0.1421 | Kyrgyzstan |
| 2020s | 22.36 | 31.76 | 9.41 | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher total official development assistance to medical research and basic, Guinea-Bissau or Kyrgyzstan?
- Kyrgyzstan, at 18.4 against 15.3 in Guinea-Bissau as of 2024.
- What is the difference in total official development assistance to medical research and basic between Guinea-Bissau and Kyrgyzstan?
- 3.1, with Kyrgyzstan ahead.
- How many years of comparable data are there for Guinea-Bissau and Kyrgyzstan?
- 15 years are reported by both, from 2010 to 2024.
- How do Guinea-Bissau and Kyrgyzstan rank globally for total official development assistance to medical research and basic?
- Guinea-Bissau ranks 76th and Kyrgyzstan ranks 74th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Total official development assistance to medical research and basic health sectors, net disbursement, by recipient countries (millions of constant 2024 United States dollars). Statizoid refreshes it automatically from the source and publishes the full history for both places.